Nasdaq Grants GT Biopharma Additional 180 Days To Regain Compliance

Benzinga Newsdesk www.benzinga.com Neutral 93.3%

Neg 0% Neu 93.3% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/109657/000149315226024913/form8-k.htm

Comments

No comments yet. Be the first!